ELOX

Conviction 0HealthcareScan · Thu, Jun 25, 2026

Hanging man

ELOX$10.70-10.83%

ResistanceSupportVol 14

Jun 9Jun 11Jun 15Jun 18Jun 23Jun 25

Eloxx Pharmaceuticals, Inc.Biological Products, (No Diagnostic Substances)www.eloxxpharma.com ↗

Price10.70

Change-10.83%

Gap-9.38%

Rel volume0.33×

Avg volume60.35K

Avg $ vol723.37K

SMA 20—

SMA 50—

SMA 200—

Price vs 50—

Price vs 200—

MA stack—

50/200 cross—

Supertrenddown · 19.36

RSI (14)—

MACD hist—

MACD cross—

Stoch %K / %D— / —

ADX (14)—

+DI / −DI— / —

RSI divergence—

MACD divergence—

ATR %—

ADR %—

52w high14.70

52w low10.70

From 52w high-27.21%

Above 52w low+0.00%

New 52w highNo

SqueezeOff

Bollinger width—

%B—

Donchian pos—

Donchian high—

Donchian low—

AVWAP (52w high)13.24

vs AVWAP high-19.20%

AVWAP (52w low)12.37

vs AVWAP low-13.50%

OBV trend—

Chaikin MF (20)—

Today vs 20d0.33×

Avg vol (14d)—

Avg vol (20d)60.35K

Avg $ vol (20d)723.37K

Market cap81.04M

RS 3m (vs SPY)—

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank1.7

1 week-23.57%

1 month—

3 months—

6 months—

1 year—

YTD-2.82%

P/E-13.52

P/B-10.69

P/S—

P/FCF-12.68

EPS-0.4900

Div yield—

ROE79.05%

ROA-70.50%

Debt/Eq0.00

Current0.53

EV/EBITDA-11.68

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth-90.74%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value74.68M

Revenue0

Net income-3.75M

Gross profit—

Free cash flow-6.39M

IndustryBiological Products, (No Diagnostic Substances)

ExchangeNasdaq

Shares out3.92M

Employees7

ListedFri, Dec 11, 1998

Free float30.84K

Float %0.4%

Short interest8.34K

Days to cover0.1d

Short volume21.5%

Squeeze score40 / 100

Next earningsMon, Aug 3, 2026 (39d)

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank1.7 / 100

Group rank—

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmHanging man

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ELOX

All disclosures →

No recent disclosed trades by Congress in ELOX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ELOX · 6 buys · 2 sells

Insider	Side	Shares	Value	Traded	Filed
Aggarwal Sumit President and CEO · Stock Option (Right to Buy) · 2026-06-10	Grant	328.83K	$0	2026-06-10	2026-06-10
Kjellson Nina S Director · Stock Option (Right to Buy) · 2026-06-08	Grant	13.59K	$0	2026-06-08	2026-06-10
Rubin Steven D Director · Stock Option (Right to Buy) · 2026-06-08	Grant	4.02K	$0	2026-06-08	2026-06-10
Walts Alan Edmund Director · Stock Option (Right to Buy) · 2026-06-08	Grant	8.59K	$0	2026-06-08	2026-06-10
Webster Stephen W Director · Stock Option (Right to Buy) · 2026-06-08	Grant	13.59K	$0	2026-06-08	2026-06-10
Domicilium Real Estate Fund III LP 10% owner · Pre-funded Warrant · 2026-05-27	Acquire	113.64K	—	2026-05-27	2026-06-05
Domicilium Real Estate Fund III LP 10% owner · Pre-funded Warrant · 2026-05-27	Other	—	—	2026-05-27	2026-06-05
Domicilium Real Estate Fund III LP 10% owner · Common Stock, $0.01 par value per share · 2026-05-27	Dispose	113.64K	$0	2026-05-27	2026-06-05
Domicilium Real Estate Fund III LP 10% owner · Common Stock, $0.01 par value per share · 2026-05-27	Other	—	—	2026-05-27	2026-06-05
Coastlands Capital LP 10% owner · Common Stock · 2026-05-27	Dispose	1.25M	$0	2026-05-27	2026-05-29

SEC filings

EDGAR filings in ELOX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.